NCT02301494: Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma |
|
|
| Withdrawn | N/A | 0 | NA | 3.75% Imiquimod Cream, Zyclara 3.75%, 0.1% Fluocinonide Cream, Vanos | Rochester General Hospital, Bausch Health Americas, Inc., Rochester Skin Lymphoma Medical Group, PLLC | Mycosis Fungoides | 04/22 | 04/23 | | |
